Protocol Title: MACS sorting of TAMs from human lung tumor tissues
- Prepare single-cell suspension from human lung tumors using the Tumor Dissociation Kit (Order no. 130-095-929, Miltenyi Biotec) according to the manufacturer’s instructions.
- Perform magnetic sorting of macrophages from single-cell suspensions using primary antibody, human CD68-PE (Order no. 130-118-486, Miltenyi Biotec) and secondary antibody, anti-PE MicroBeads (Order no. 130-048-801, Miltenyi Biotec) according to the instructions provided by the manufacturer.
Protocol Title: MACS sorting of TAMs from mouse lung tumor tissues
- Fragment mouse tumor tissues (0,5 gm) into small pieces.
- Incubate in 2mL of RPMI medium with collagenase (5 μg/μl), DNase (10 μg/μl), and 1%P/S for 30 min at 37°C, mixing 300 rpm.
- Pass cell suspension through 70µM cell strainer.
- Centrifuge at 500 g, 10 min, 4°C.
- Pellet down and resuspend the pellet in 5mL of 1X RBC lysis buffer, followed by 15 mins of incubation at RT.
- Add 10 mL 1X PBS.
- Centrifuge at 500 g, 10 min, 4°C.
- Add 10 mL 1X PBS.
- Centrifuge at 500 g, 10 min, 4°C.
- Resuspend the pellet in MACS buffer (Miltenyi Biotec) supplemented with 5% BSA and count the number of cells.
- Perform magnetic sorting of macrophages from single-cell suspension using primary antibody, F4/80-PE mouse (Order no. 130-116-499, Miltenyi Biotec) and secondary antibody, anti-PE MicroBeads (Order no. 130-048-801, Miltenyi Biotec) according to the instructions provided by the manufacturer.
Copyright: Content may be subjected to copyright.
How to cite:Readers should cite both the Bio-protocol preprint and the original research article where this protocol was used:
- Sarode, P A and Savai, R(2021). MACS sorting of TAMs from human and mouse lung tumor tissues. Bio-protocol Preprint. bio-protocol.org/prep847.
- Sarode, P., Zheng, X., Giotopoulou, G. A., Weigert, A., Kuenne, C., Günther, S., Friedrich, A., Gattenlöhner, S., Stiewe, T., Brüne, B., Grimminger, F., Stathopoulos, G. T., Pullamsetti, S. S., Seeger, W. and Savai, R.(2020). Reprogramming of tumor-associated macrophages by targeting β-catenin/FOSL2/ARID5A signaling: A potential treatment of lung cancer . Science Advances 6(23). DOI: 10.1126/sciadv.aaz6105
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.
Post a Question 0 Q&A